Invivyd Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.91

-0.11 (-10.67%)

As of Sep 22, 3:00 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +2,257.3% upside

Low Target $15.01

Average Target $21.48

High Target $34.49

Current Price $0.91

Current
$0.91

Target
$21.48

$15.01 $21.48 avg $34.49

Scenario Analysis

Bear Case

$15.01

1,547.3%

Low target

Base Case

$21.48

+2,257.3%

Avg target

Bull Case

$34.49

+3,685.1%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$3.07

-70.3% from high

52-Week Low

$0.53

+72.7% from low

Target vs 52W High

$21.48

+599.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.9%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%